Si Wu Tang (Four Substance Decoction)

Actions

Indications

Western Uses:

• What conditions is Si Wu Tang used for in modern practice?

  Si Wu Tang is the foundational blood tonic (Liver blood deficiency — pallor, dizziness, scanty or irregular periods, dry skin), so it is referenced chiefly for gynaecological and blood-deficiency conditions: painful periods (dysmenorrhoea), irregular menstruation, premenstrual syndrome, anaemia, threatened miscarriage, postpartum weakness, insufficient lactation, hives (urticaria), and blood-deficiency ("neurogenic") headache.

  The thread is the Liver-blood-deficiency pattern, not any one diagnosis. Threatened miscarriage is an obstetric emergency requiring immediate medical care; anaemia needs diagnosis (its causes range from diet to internal bleeding); and abnormal bleeding must be assessed. This base tonic is a traditional adjunct, not a substitute. Traditional-use correlates only, not a treatment claim.

  Source: Sacred Lotus sources & references (pattern) + Bensky & Barolet, Formulas & Strategies; biomedical correlates as reference only. Not medical advice.

Originally Appeared In:

• Imperial Grace Formulary of the Tai Ping Era (Tai Ping Hui Min He Ji Ju Fang)

Notes:

• How does Si Wu Tang relate to Ba Zhen Tang, Tao Hong Si Wu Tang, and other formulas?

  Si Wu Tang is the parent formula of an entire family of Blood-related prescriptions built by adding Qi tonics, stronger Blood-movers, or hemostatic herbs to its four-herb base.

  • Ba Zhen Tang (Eight Treasure Decoction): Si Wu Tang + Si Jun Zi Tang (Ren Shen, Bai Zhu, Fu Ling, Zhi Gan Cao) — adds Qi tonification for combined Qi-and-Blood deficiency.
  • Shi Quan Da Bu Tang: Ba Zhen Tang + Huang Qi + Rou Gui — a stronger, warming Qi-Blood-Yang tonic for chronic deficiency with cold.
  • Tao Hong Si Wu Tang: Si Wu Tang + Tao Ren + Hong Hua — shifts the balance from tonify-with-movement toward stronger Blood-invigoration, for dysmenorrhea or amenorrhea with dark clots and fixed, stabbing pain — more pronounced Blood stasis than Si Wu Tang alone addresses.
  • Sheng Yu Tang: Si Wu Tang + Ren Shen + Huang Qi — adds Qi tonics to help generate and hold Blood, used for Qi-and-Blood deficiency with excessive uterine bleeding or profuse flow.
  • Jiao Ai Tang and the Wen Jing Tang family: built on a Si Wu Tang base with E Jiao, Ai Ye, and warming herbs added, for uterine bleeding or menstrual disorders with an underlying cold or deficiency component.

  Classical source and lineage: Si Wu Tang is recorded in the Song-dynasty imperial formulary Tai Ping Hui Min He Ji Ju Fang (“Formulas of the Peaceful Benevolent Dispensary”), with its composition traced to the earlier Tang-dynasty text Xian Shou Li Shang Xu Duan Mi Fang, where it originated as a trauma/Blood-stasis formula before its gynecological role became dominant.

  Source: Bensky & Barolet, Formulas & Strategies (2nd ed.) — formula family and classical-source lineage.

Clinical Studies & Research:

• Is there modern research on Si Wu Tang?

  Yes — Si Wu Tang has been studied in randomized human trials as well as animal models, mostly around menstrual pain, antioxidant/skin markers, and Blood-building (hematopoietic) effects.

  • Primary dysmenorrhea (clinical, RCT): a placebo-controlled pilot trial in 78 young women found no significant difference in period pain by the end of the treatment cycle itself, but a delayed reduction in pain emerged in the following cycle among women who completed a full course (PMID 17710126).
  • Antioxidant, liver, and skin markers (clinical, RCT): a 6-month randomized, double-blind, placebo-controlled crossover trial in healthy adults reported increased antioxidant enzyme activity, improved lipid/liver markers, and measurable skin-hydration and texture changes with daily use (PMID 27375769).
  • Anemia/hematopoiesis (preclinical): in a chronic-renal-failure rat model, Siwu granules combined with erythropoietin raised hemoglobin levels and reduced oxidative-stress markers more than either treatment alone (PMID 31915448).

  Sources: PMID 17710126; PMID 27375769; PMID 31915448. Research context only, not a therapeutic claim.